American Century Companies Inc. Sells 2,751 Shares of Oscar Health, Inc. (NYSE:OSCR)

American Century Companies Inc. trimmed its stake in Oscar Health, Inc. (NYSE:OSCR) by 0.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 880,255 shares of the company’s stock after selling 2,751 shares during the period. American Century Companies Inc. owned 0.39% of Oscar Health worth $4,903,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Southeastern Asset Management Inc. TN increased its position in Oscar Health by 30.8% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 14,576,904 shares of the company’s stock valued at $35,859,000 after buying an additional 3,430,032 shares in the last quarter. BlackRock Inc. increased its position in Oscar Health by 10.3% during the 2nd quarter. BlackRock Inc. now owns 12,397,356 shares of the company’s stock valued at $99,923,000 after buying an additional 1,155,528 shares in the last quarter. Vanguard Group Inc. increased its position in Oscar Health by 13.4% during the 3rd quarter. Vanguard Group Inc. now owns 11,215,680 shares of the company’s stock valued at $55,966,000 after buying an additional 1,329,461 shares in the last quarter. Dragoneer Investment Group LLC increased its position in Oscar Health by 4.9% during the 2nd quarter. Dragoneer Investment Group LLC now owns 8,149,862 shares of the company’s stock valued at $65,688,000 after buying an additional 383,598 shares in the last quarter. Finally, State Street Corp increased its position in Oscar Health by 12.7% during the 2nd quarter. State Street Corp now owns 3,207,395 shares of the company’s stock valued at $25,852,000 after buying an additional 361,233 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on OSCR shares. Wells Fargo & Company upped their target price on Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. The Goldman Sachs Group boosted their price target on Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research note on Friday, February 9th. TheStreet raised Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Finally, Raymond James initiated coverage on Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price objective on the stock. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $13.50.

Oscar Health Stock Up 1.9 %

Oscar Health stock opened at $14.22 on Thursday. The firm has a market cap of $3.27 billion, a price-to-earnings ratio of -11.85 and a beta of 1.82. Oscar Health, Inc. has a 52 week low of $4.72 and a 52 week high of $18.55. The business’s 50-day moving average price is $14.59 and its 200 day moving average price is $9.79. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping the consensus estimate of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. Oscar Health’s revenue for the quarter was up 43.9% compared to the same quarter last year. During the same period last year, the company earned ($1.05) earnings per share. As a group, sell-side analysts anticipate that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.